Evidence map›Paper›PMID 24656842›Full record

ReviewMedecine et maladies infectieuses2014

Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance.

G G Aubin, M E Portillo, A Trampuz, S Corvec

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medecine et maladies infectieuses, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Evidence for infection in intervertebral disc degeneration: a systematic review.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. In vitro emergence of amoxicillin-resistance and impact of amoxicillin on biofilm production across Cutibacterium acnes phylotypes?European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  6. Antibiotics (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Cutibacterium acnes in lumbar spine, from skin to deep tissue. A colonization study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Article
  9. From adhesion to destruction: minocycline's dual action against Cutibacterium acnes biofilms.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  10. Article
  11. Article
  12. Clinics in orthopedic surgery · 2024
    Review
  13. Article
  14. Comparative Genomic Analysis ofMicroorganisms · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

G G AubinService de Bactériologie-Hygiène, Institut de biologie des hôpitaux de Nantes, CHU de Nantes, 9, quai Moncousu, 44093 Nantes cedex 01, France; EA3826 Thérapeutiques cliniques et expérimentales des infections, Université de Nantes, faculté de médecine, 44000 Nantes, France.
M E PortilloMicrobiology Laboratory, Laboratori de Referència de Catalunya, Carrer de la Selva, 10, Edifici Inblau A. Parc de Negocis Mas Blau, 08820 El Prat de Llobregat, Barcelona, Spain.
A TrampuzCharité - University Medicine Free and Humboldt-University of Berlin Charitéplatz, 1D-10117 Berlin, Germany.
S CorvecService de Bactériologie-Hygiène, Institut de biologie des hôpitaux de Nantes, CHU de Nantes, 9, quai Moncousu, 44093 Nantes cedex 01, France; EA3826 Thérapeutiques cliniques et expérimentales des infections, Université de Nantes, faculté de médecine, 44000 Nantes, France. Electronic address: stephane.corvec@chu-nantes.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Propionibacterium acnes colonizes the lipid-rich sebaceous glands of the skin. This preferential anaerobic bacterium is easily identified if cultures are prolonged. It is involved in the inflammation process of acne, but until recently, it was neglected in other clinical presentations. Despite a reported low virulence, the new genomic, transcriptomic, and phylogenetic studies have allowed better understanding of this pathogen's importance that causes many chronic and recurrent infections, including orthopedic and cardiac prosthetic, and breast or eye implant-infections. These infections, facilitated by the ability of P. acnes to produce a biofilm, require using anti-biofilm active antibiotics such as rifampicin. The antibiogram of P. acnes is not systematically performed in microbiology laboratories because of its susceptibility to a wide range of antibiotics. However, in the last 10 years, the rate of antibiotic-resistant bacteria has increased, especially for macrolides and tetracyclines. Recently, rpoB gene mutations conferring resistance to rifampicin have been also reported. Thus in case of a biofilm growth mode, the therapeutic strategy should be discussed, according to the resistance phylotype and phenotype so as to optimize the treatment of these severe infections.

Indexed as

Communicable Diseases, EmergingAcne VulgarisAnti-Bacterial AgentsBacterial ProteinsBacterial Typing TechniquesBiofilmsBreast ImplantsCerebrospinal Fluid ShuntsDNA, BacterialDrug Resistance, Multiple, BacterialEndophthalmitisEye Infections, BacterialGenome, BacterialGram-Positive Bacterial InfectionsHost-Pathogen InteractionsHumansAnti-Bacterial AgentsBacterial ProteinsDNA, BacterialAcneAcnéAntibiotic resistancePhylotypeProsthesis or device-related infectionsProthèseRésistance aux antibiotiques

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.